CEL-SCI (CVM) Hires CRO for Clinical Study With Hospitalized H1N1-Infected Patients
Tweet Send to a Friend
CEL-SCI Corporation (NYSE: CVM) hired a full-service Clinical Research Organization (CRO) with an office in the Washington, D.C./Baltimore area to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


